This page shows the details of why an item matched the keywords from your search.
| Property | Value |
|
has minor subject area list
|
Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fibroblast Growth Factor 10; Humans; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome
|
|
information resource reference
|
Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Aliment Pharmacol Ther. 2003 Jun 01; 17(11):1355-64.
|
|
label
|
Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
|